Partnerships in Technology Transfer: The NIH Experience
Luis A. Salicrup, Ph.D.Senior Advisor for International ActivitiesOffice of Technology TransferNational Institutes of HealthU.S. Department of Health & Human Services
FLC MeetingSeptember 14, 2005
NIH Mission
To uncover new knowledge that will lead to improved
public health
National Institutes of HealthBasic Biomedical Research in Support of the Public Health
Funding
Training
Basic Research
Clinical Trials
Inventions
Policies
Importance of Global Health Research
Humanitarian Objectives
Globalization of Health Problems
and their Relevance to Domestic Health
Economic Development and Political Stability
Relevance of Technology Transfer to Institutions in Developing Countries
Innovation of all types
National, regional and global needs
Reduction of the burden of disease worldwide
10/90 GAP
New Trends in Health Entities in LDCs• Increase in public-private partnerships• Developing countries (India, Brazil,
China, South Africa) strengthening investments in biotechnology research of endemic and neglected diseases
• Developing country institutions entering various types of R&D agreements for transferring technologies
Partners for Global Health
NIH OTT currently active exploring ways to enhance the process of transferring technologies to institutions in: – Asia
– Latin America
– Africa
– Eastern Europe
Collaborative work with institutions in developing countries has revealed needs and opportunities for transfer of NIH technologies related to:
• HIV/AIDS• Tuberculosis• Malaria• Dengue• Pertussis• Meningitis
• Rotavirus• Typhoid Fever• Cancer • Diabetes• Medical Devices &
Animal Models
Capacity Building at NIH-OTT
Information Access
Combined initiative by NIH-OTT and U.S. academic institutions
Database of technologies for neglected diseases
Resource tool for managers and scientists in developing countries
International Technology Transfer Internship Program
Aimed to train Scientists and Managers
Provide key exposure & practical experience
Long & Sustainable Process
Partnerships with several institutions in Asia, Africa, Latin America, and Eastern Europe
Program Objectives
• Learn different aspects of IPM• Assessment & Commercialization of
Technologies • Exposure to practical aspects of
negotiation license agreement• Enhance understanding IPR Policy• Understand Global Challenges
– Clinical Trials– Capacity Building– Public-Private Partnerships
Training Implementation
Rotations will depend on the needs of partners
• Different OTT Divisions and/or • NIH’s ICs’ Offices of Technology
Development• U. S. Academic Institutions
Mentors (sustainable relationship)
First Phase: Staff from institutions in China, Brazil, South Africa, India, Argentina, Hungary
Additional Training
Participation in FAES/NIH TT Course
Participation in Seminars at OTT & NIH
Workshops in the field--Partners
Relevant courses & guidance at U.S. Universities
Participation in relevant professional meetings (e.g. AUTM, FLC, BIO)
Lessons Learned
Participating institutions should have – Some level of R&D capabilities– Clear objectives to address national and
regional public health needs
Need to work with public and private institutions in those countries
Comprehensive, multidisciplinary, sustainable training approach
Next Steps: Evaluation/Needs Assessment
ACCESSIBLE DRUGS,
DIAGNOSTICS,THERAPEUTICS
REDUCTION OF DISEASE BURDENS
(INFECTIOUS & CHRONIC)
POVERTY REDUCTION &
POTENTIAL ECONOMIC GROWTH
HEALTH TECHNOLOGIES
INNOVATION
RESEARCH & DEVELOPMENT
CAPACITY BUILDING INDEVELOPING COUNTRIES
NIH CONTACTS
• NIH http://www.nih.gov• OTT http://ott.od.nih.gov• TT Training http://tttraining.od.nih.gov• Clinical Trials http://clinicaltrials.gov
E-mail: [email protected]
Health for All!
